Why Attend
Targeting RNA is set to be the next big thing; 85% of human genome transcribed to RNA but only 3% translated into proteins, therefore making it an obvious target. With Risdiplam being approved by the FDA in August, and several major collaborations also being penned throughout 2020, including a $190 million deal between Arrakis and Roche, it seems like a good time to target these protein precursors.
Targeting RNA 2021 will take a look at the latest techniques to analyse and predict protein structure, as well as hearing from leading researchers and industry on how to incorporate learnings from RNA biology into potent and selective ligands to help prevent, rather than treat, disease.
Why attend this year?
- Learn where to target your RNA molecules after exploring the newest biophysical techniques to analyse RNA structure, including NMR, Cryo-EM, and in silico modelling with Silvi Rouskin, (MIT), Wah Chiu (Stanford University) and Hashim Al Hashimi (Duke University).
- Understand what makes a druggable RNA target and hear from expert RNA biologists to advise how best to drug your favourite RNA targets with Anima Biotech and Craig Blain (Arrakis).
- Get translational insights into what considerations are important when creating a small molecule that targets RNA by learning how to develop tools for assessment of RNA targets with Amanda Garner (University of Michigan)
- Hear what new techniques can help to drug these tricky targets, including RNAi, RNA degraders and RIBOTACs with Gene Yeo (UCSD), Jonathan Hall (Zurich) and Matt Disney (Scripps and Expansion).
Who Attended Targeting RNA 2019
-
Pharma30%
-
Biotech20%
-
Academic & Research Institutes30%
-
Service Providers15%
-
Clinicians5%
Join the FREE webinar: Small molecule targeted degradation of RNA via Ribonuclease recruitment
Date: February 3 2021
Time: 2pm EST | 7:00pm GMT | 11:00am PST
Hear Matt Disney Professor, Scripps institute and Founder, Expansion Therapeutics discuss:
- The latest in ribonuclease targeting chimeras (RIBOTACs)
- How to recruit cellular nucleases to selectively destroy RNA using RNase L
- How to selectively and potently modulate RNA function in vivo
Book your free place
The Virtual Experience
Top 10 benefits
- Tailor Your Agenda
- More Audience Participation
- Improved Audience Visibility
- On-Demand Content
- High Quality Speakers
- More Networking Opportunities
- Save Time & Money
- Increased Content
- More insights
- Business Development Opportunities - Talk to our team to find out out more [email protected].
Platform Preview
Speakers
Amanda Garner
Silvi Rouskin
Rouskin came to the United States as an exchange student from Bulgaria when she was 15 years old and tested out of high school by obtaining a GED. She then enrolled at Florida Institute of Technology and earned a bachelor's degree in physics. After graduation, Silvi worked as a research technician at University of California San Francisco (UCSF), using cutting-edge technology to detect and track viral infections. She stayed at UCSF for her PhD in the lab of Jonathan Weissman, where she developed new approaches to study RNA folding in physiological conditions and on a genome-wide scale. After she finished her PhD in biochemistry and molecular biology, Rouskin joined the Whitehead Institute as a principal investigator in 2015. Her lab studies the RNA structure and function of viruses including HIV-1 and SARS-Cov2.
Craig Blain
Jack Rogers
Wah Chiu
Jonathan Hall
Francois Fuks
Gene Yeo
Rachel Green
Sarah Woodson
Sarah Woodson is the T. C. Jenkins Professor of Biophysics at Johns Hopkins University. She received her PhD in Biophysical Chemistry in 1987 with Donald Crothers at Yale University, and did postdoctoral research in the laboratory of Thomas Cech at the University of Colorado Boulder. Her research group studies how RNA molecules fold into specific three-dimensional structures, and how the RNA and proteins components of cellular complexes such as the ribosome come together. Dr. Woodson was elected a AAAS Fellow, the President of the RNA Society and received the Lifetime Service Achievement Award from the RNA Society in 2020.
Marcel Blommers
Jay Schneekloth
Matt Disney
Hien Zhao
Become a media partner
If you're interested in becoming a media partner, please contact Katie Horne:
[email protected]
Partners
Media Partners
Drug Discovery World
Website: https://www.ddw-online.com/
Drug Discovery World is the multi-platform global voice for the drug discovery community. From research stage to clinical trials the brand covers the scientific and commercial process involved in getting a drug to market–research, target identification and validation, drug molecule identification, lead molecule optimisation, pre-clinical research, clinical trial authorisation and application, and clinical trials phase I and II. DDW readers learn how to turn science into business.
DDW is available as a quarterly printed publication, online and as a free-to-download app containing trusted content as well as premium hand-picked intelligence for anyone involved in drug discovery and development. Readers can also sign up for our free weekly e-newsletter.
From bench through to boardroom DDW offers commercial insight for researchers, scientists and decision-makers involved in drug discovery and development. We cover the latest news and events in the global pharmaceutical, biopharmaceutical and biotech sectors, as well as the technology and processes to help create vaccines, therapeutics and drugs.
PARTNER WITH US
Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]
The Agenda
Please download our 2021 agenda to find out more information about the congress including the main topics of discussion for the three days and preview lineup of speakers.
Download Agenda
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.